These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 7029774
21. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice. Hansen DK, Hodes ME. Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790 [Abstract] [Full Text] [Related]
22. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Robertson IG, Serabjit-Singh C, Croft JE, Philpot RM. Mol Pharmacol; 1983 Jul; 24(1):156-62. PubMed ID: 6865923 [Abstract] [Full Text] [Related]
23. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009). Yamazaki H, Shimada T. Biochem Pharmacol; 1992 Sep 01; 44(5):913-20. PubMed ID: 1530660 [Abstract] [Full Text] [Related]
24. Effects of beta-naphthoflavone administration to pregnant rats on steroid hormone biosynthesis and metabolism in ovarian microsomes. Fuhrman-Lane C, Ortiz E, Shiverick KT. J Pharmacol Exp Ther; 1983 Oct 01; 227(1):248-53. PubMed ID: 6620170 [Abstract] [Full Text] [Related]
25. Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule. Belinsky SA, Kari FW, Kauffman FC, Thurman RG. Mol Pharmacol; 1987 Aug 01; 32(1):315-20. PubMed ID: 3497333 [Abstract] [Full Text] [Related]
26. Influence of Aroclor 1254, phenobarbital, beta-naphthoflavone, and ethanol pretreatment on the biotransformation of cyclophosphamide in male and female rats. Sessink PJ, Vaes WH, van den Broek PH, de Roos JH, Noordhoek J, Bos RP. Toxicology; 1996 Aug 16; 112(2):141-50. PubMed ID: 8814343 [Abstract] [Full Text] [Related]
27. NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice. Chhabra RS. Toxic Rep Ser; 2000 Apr 16; (61):1-53, A1-13. PubMed ID: 11803700 [Abstract] [Full Text] [Related]
28. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450. Yu L, Waxman DJ. Drug Metab Dispos; 1996 Nov 16; 24(11):1254-62. PubMed ID: 8937861 [Abstract] [Full Text] [Related]
29. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Hakura A, Shimada H, Nakajima M, Sui H, Kitamoto S, Suzuki S, Satoh T. Mutagenesis; 2005 May 16; 20(3):217-28. PubMed ID: 15843387 [Abstract] [Full Text] [Related]
30. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity. Yu LJ, Drewes P, Gustafsson K, Brain EG, Hecht JE, Waxman DJ. J Pharmacol Exp Ther; 1999 Mar 16; 288(3):928-37. PubMed ID: 10027828 [Abstract] [Full Text] [Related]
31. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A. Oesch-Bartlomowicz B, Vogel S, Arens HJ, Oesch F. Mutat Res; 1990 Oct 16; 232(2):305-12. PubMed ID: 2170835 [Abstract] [Full Text] [Related]
32. Mutagenicity of urine from rats after administration of 2,4-diaminoanisole: the effect of microsomal enzyme inducers. Reddy TV, Benjamin T, Grantham PH, Weisburger EK, Thorgeirsson SS. Mutat Res; 1980 Dec 16; 79(4):307-17. PubMed ID: 7003374 [Abstract] [Full Text] [Related]
33. Modification of transplacental tumorigenesis by 3-methylcholanthrene in mice by genotype at the Ah locus and pretreatment with beta-naphthoflavone. Anderson LM, Jones AB, Riggs CW, Kovatch RM. Cancer Res; 1989 Apr 01; 49(7):1676-81. PubMed ID: 2538231 [Abstract] [Full Text] [Related]
34. Aging modifies the expression of hepatic microsomal cytochromes P-450 after pretreatment of rats with beta-naphthoflavone or phenobarbital. Sun JQ, Lau PP, Strobel HW. Exp Gerontol; 1986 Apr 01; 21(2):65-73. PubMed ID: 3758228 [Abstract] [Full Text] [Related]
35. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450. Iba MM. Mutat Res; 1987 Oct 01; 182(5):231-41. PubMed ID: 3309638 [Abstract] [Full Text] [Related]
36. Inhibition of cyclophosphamide mutagenicity by beta-carotene. Belisario MA, Pecce R, Battista C, Panza N, Pacilio G. Biomed Pharmacother; 1985 Oct 01; 39(8):445-8. PubMed ID: 3914914 [Abstract] [Full Text] [Related]
37. Mutagenicity of structurally related aromatic amines in the Salmonella/mammalian microsome test with various S-9 fractions. Shahin MM, Chopy C, Mayet MJ, Lequesne N. Food Chem Toxicol; 1983 Oct 01; 21(5):615-9. PubMed ID: 6360828 [Abstract] [Full Text] [Related]
38. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver. Hales BF, Jain R. Biochem Pharmacol; 1980 Feb 01; 29(2):256-9. PubMed ID: 6767482 [No Abstract] [Full Text] [Related]
39. A comparison of avian and rodent S-9 liver homogenates in the Ames test. Rosanoff KA, Jones DH, Sawyer TW. Res Commun Chem Pathol Pharmacol; 1984 Apr 01; 44(1):131-9. PubMed ID: 6328598 [Abstract] [Full Text] [Related]
40. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines. Hellmold H, Overvik E, Strömstedt M, Gustafsson JA. Carcinogenesis; 1993 Sep 01; 14(9):1751-7. PubMed ID: 8403195 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]